Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selma Ugurel

Showing results (141-150 of 265) with videos related to

Pageof 27
Sort By:
Journal for Immunotherapy of Cancer|May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2024
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node statusViola K DeTemple, Cathrin Ritter, Nalini Srinivas, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 11, 2021
Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
Frontiers in Oncology|August 30, 2021
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryJan-Malte Placke, Josefine Rawitzer, Henning Reis, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 25, 2021
S1-Guideline Cutaneous Angiosarcomas - Update 2021Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
The Journal of Investigative Dermatology|February 25, 2006
Absence of classical MAP kinase pathway signalling in Merkel cell carcinomaRoland Houben, Barbara Michel, Claudia S Vetter-Kauczok, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2021
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell CarcinomaJustin Ferdinandus, Wolfgang P Fendler, Katharina Lueckerath, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Pageof 27

Showing results (141-150 of 265) with videos related to

Sort By:
Pageof 27
Journal for Immunotherapy of Cancer|May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2024
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node statusViola K DeTemple, Cathrin Ritter, Nalini Srinivas, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 11, 2021
Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
Frontiers in Oncology|August 30, 2021
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition - Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryJan-Malte Placke, Josefine Rawitzer, Henning Reis, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 25, 2021
S1-Guideline Cutaneous Angiosarcomas - Update 2021Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
The Journal of Investigative Dermatology|February 25, 2006
Absence of classical MAP kinase pathway signalling in Merkel cell carcinomaRoland Houben, Barbara Michel, Claudia S Vetter-Kauczok, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2021
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell CarcinomaJustin Ferdinandus, Wolfgang P Fendler, Katharina Lueckerath, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Pageof 27